Related by context. Frequent words. (Click for all words.) 75 Patient Enrollment 71 Achieves Milestone 70 Momentum Continues 69 Drug Candidate 69 FY# Guidance 69 RNAi Therapeutics 69 Organizational Changes 69 Upcoming Conferences 69 Cholesterol Drug 69 Updates Guidance 69 Clinical Trial Results 68 Completes Enrollment 68 Successful Completion 68 Annual Meeting Date 68 Significantly Increases 68 Preclinical Data 68 Secures Financing 68 Q2 Loss Widens 68 Develop Next Generation 68 Q3 Loss Narrows 68 Develop Novel 67 FDA Clears 67 Opns 67 FDA Accepts 67 Share Repurchases 67 Secures Additional 67 CFO Resigns 67 Reaffirms Guidance 67 Reconfirms 67 Takeover Speculation 67 Q2 Loss Narrows 67 Explore Strategic Alternatives 67 Closes Financing 67 Provides Guidance 66 Guidance Quick Facts 66 Accelerate Growth 66 Malaria Vaccine 66 Vertex Pharmaceuticals Announces 66 Cervical Cancer Vaccine 66 Q1 Loss Widens 66 StockSource.us Reports 66 Previously Announced 66 Q1 Loss Narrows 66 Phase III Clinical Trial 66 Cost Reductions 66 Single Dose 66 Quadruples 66 Sixth Consecutive Year 66 Patent Lawsuit 66 Exercises Option 66 Prostate Cancer Patients 66 Report Analyzes 66 Shareholder Letter 66 Shares Soar 66 Updates Shareholders 66 Q3 Loss Widens 66 Phase III Trial 66 Stock Buyback 65 Significant Increase 65 Record Second Quarter 65 Diversifies 65 Forecast Quick Facts 65 Secures Funding 65 Announces Initiation 65 Completes Financing 65 Lifts FY# EPS 65 Completes Tender Offer 65 Multi Billion Dollar 65 Double Digit Growth 65 Final Stages 65 Stock Soars 65 Licensing Agreements 65 Option Grants 65 Provides Updates 65 Record Third Quarter 65 Presents Positive 65 Guides Q4 65 Announces Publication 65 Files Shelf Registration Statement 65 Patent Infringement Lawsuit 65 Explosive Growth 65 Deliver Comprehensive 65 Share Buyback Program 65 Backs FY# EPS 65 Expand Relationship 65 Posts Wider Loss 65 Lowers Guidance 64 Renewable Energy Projects 64 Shareholder Lawsuit 64 Upcoming Investor Conferences 64 Generic Version 64 Announces Organizational Changes 64 Net Loss Narrows 64 Q1 Profit Surges 64 Analyst Upgrade 64 Extends Tender Offer 64 Complete Merger 64 Guides Q3 64 Smallpox Vaccine 64 Robust Growth 64 Planned Acquisition